EUVIMEDEUVIMED entdecken
Crossref

Identity, Potency, In Vivo Viability, and Scaling Up Production of Lentiviral Vector-Induced Dendritic Cells for Melanoma Immunotherapy

Mudita Pincha, Bala Sai Sundarasetty, Gustavo Salguero, Ralf Gutzmer, Henk Garritsen, Laura Macke, Andreas Schneider, Daniela Lenz, Constanca Figueiredo, Rainer Blasczyk, Eliana Ruggiero, Manfred Schmidt und 7 weitere

Human Gene Therapy Methods · 2012

DOI: 10.1089/hgtb.2011.170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Gene Therapy Methods, 2012. Verfasst von Mudita Pincha und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, 30625, Germany. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsBiotechnologyBlotting, WesternCell LineCryopreservationCytokinesDNA PrimersDendritic CellsFlow CytometryFluoresceinsGenes, RAG-1Genetic VectorsHumansImmunotherapyInterleukin Receptor Common gamma SubunitLentivirusMelanomaMembrane ProteinsMiceMice, Knockout

Substanzen

5-(6)-carboxyfluorescein diacetate succinimidyl esterCytokinesDNA PrimersFluoresceinsIL2RG protein, humanInterleukin Receptor Common gamma SubunitMembrane ProteinsPeptide FragmentsSuccinimidespeptide SVYDFFVWL

Autor:innen und Institutionen

  • Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, 30625, Germany.

Förderung

  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Pincha, M., Sundarasetty, B. S., Salguero, G., Gutzmer, R., Garritsen, H., Macke, L., Schneider, A., Lenz, D., Figueiredo, C., Blasczyk, R., Ruggiero, E., Schmidt, M., von Kalle, C., Puff, C., Modlich, U., von der Leyen, H., Wicke, D. C., Ganser, A., & Stripecke, R. (2012). Identity, Potency, In Vivo Viability, and Scaling Up Production of Lentiviral Vector-Induced Dendritic Cells for Melanoma Immunotherapy. Human Gene Therapy Methods. https://doi.org/10.1089/hgtb.2011.170

Vancouver

Pincha M, Sundarasetty BS, Salguero G, Gutzmer R, Garritsen H, Macke L, et al. Identity, Potency, In Vivo Viability, and Scaling Up Production of Lentiviral Vector-Induced Dendritic Cells for Melanoma Immunotherapy. Human Gene Therapy Methods. 2012. doi:10.1089/hgtb.2011.170

BibTeX
@article{Pincha2012,
  author = {Pincha, Mudita and Sundarasetty, Bala Sai and Salguero, Gustavo and Gutzmer, Ralf and Garritsen, Henk and Macke, Laura and Schneider, Andreas and Lenz, Daniela and Figueiredo, Constanca and Blasczyk, Rainer and Ruggiero, Eliana and Schmidt, Manfred and von Kalle, Christof and Puff, Christina and Modlich, Ute and von der Leyen, Heiko and Wicke, Daniel C and Ganser, Arnold and Stripecke, Renata},
  title = {Identity, Potency, In Vivo Viability, and Scaling Up Production of Lentiviral Vector-Induced Dendritic Cells for Melanoma Immunotherapy},
  journal = {Human Gene Therapy Methods},
  year = {2012},
  doi = {10.1089/hgtb.2011.170}
}
Kostenlos starten →